Get the Stockscreener App
14.90
2.17%
-0.33
After Hours:
15.19
0.29
+1.95%
Bausch Lomb Corp stock is traded at $14.90, with a volume of 850.98K.
It is down -2.17% in the last 24 hours and up +2.41% over the past month.
Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.
See More
Previous Close:
$15.23
Open:
$15.19
24h Volume:
850.98K
Relative Volume:
1.16
Market Cap:
$5.28B
Revenue:
$4.79B
Net Income/Loss:
$-317.00M
P/E Ratio:
-16.37
EPS:
-0.91
Net Cash Flow:
$-59.00M
1W Performance:
-2.61%
1M Performance:
+2.41%
6M Performance:
-2.93%
1Y Performance:
-16.29%
1-Day Range:
$14.89
$15.41
1-Week Range:
$14.89
$15.50
52-Week Range:
$10.45
$21.69
Bausch Lomb Corp Stock (BLCO) Company Profile
Name
Bausch Lomb Corp
Sector
Industry
Phone
908-541-5456
Address
520 APPLEWOOD CRESCENT, VAUGHAN
Compare BLCO with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
BLCO
Bausch Lomb Corp
|
14.90 | 5.39B | 4.79B | -317.00M | -59.00M | -0.91 |
|
ISRG
Intuitive Surgical Inc
|
434.50 | 155.58B | 9.15B | 2.63B | 1.99B | 7.17 |
|
BDX
Becton Dickinson Co
|
186.21 | 53.24B | 21.39B | 1.61B | 2.55B | 5.56 |
|
RMD
Resmed Inc
|
272.60 | 39.71B | 5.15B | 1.40B | 1.65B | 9.51 |
|
ALC
Alcon Inc
|
77.64 | 38.27B | 10.03B | 1.07B | 1.39B | 2.17 |
|
WST
West Pharmaceutical Services Inc
|
258.35 | 18.52B | 2.96B | 487.70M | 344.00M | 6.68 |
Bausch Lomb Corp Stock (BLCO) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| May-02-25 | Reiterated | H.C. Wainwright | Buy |
| Mar-28-25 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| Dec-11-24 | Downgrade | Citigroup | Buy → Neutral |
| Dec-02-24 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-15-24 | Upgrade | Evercore ISI | In-line → Outperform |
| Jul-10-24 | Initiated | Raymond James | Outperform |
| May-06-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Jan-04-24 | Downgrade | Evercore ISI | Outperform → In-line |
| Dec-12-23 | Initiated | Stifel | Hold |
| Oct-03-23 | Resumed | Evercore ISI | Outperform |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| Mar-09-23 | Initiated | Needham | Hold |
| Dec-21-22 | Initiated | Barclays | Equal Weight |
| Sep-12-22 | Initiated | H.C. Wainwright | Buy |
| Jul-26-22 | Initiated | RBC Capital Mkts | Outperform |
| Jun-24-22 | Initiated | Evercore ISI | Outperform |
| Jun-06-22 | Initiated | Citigroup | Buy |
| May-31-22 | Initiated | Deutsche Bank | Hold |
| May-31-22 | Initiated | Goldman | Neutral |
| May-31-22 | Initiated | Guggenheim | Buy |
| May-31-22 | Initiated | JP Morgan | Neutral |
| May-31-22 | Initiated | Jefferies | Buy |
| May-31-22 | Initiated | Morgan Stanley | Equal-Weight |
| May-31-22 | Initiated | Wells Fargo | Overweight |
| May-11-22 | Initiated | Cowen | Outperform |
View All
Bausch Lomb Corp Stock (BLCO) Latest News
Vident Advisory LLC Makes New Investment in Bausch + Lomb Corporation $BLCO - MarketBeat
Dynamic Technology Lab Private Ltd Sells 23,145 Shares of Bausch + Lomb Corporation $BLCO - MarketBeat
Clearline Capital LP Acquires 247,149 Shares of Bausch + Lomb Corporation $BLCO - MarketBeat
Cubist Systematic Strategies LLC Takes $2.12 Million Position in Bausch + Lomb Corporation $BLCO - MarketBeat
Bausch + Lomb (NYSE:BLCO): Valuation Perspective After New Clinical Data and ASANA Lens Launch - Yahoo Finance
Revolutionary Full Range Vision Lens: Bausch + Lomb's enVista Envy Succeeds in 501-Patient Trial - Stock Titan
Bausch + Lomb (BLCO) Stock Trades Up, Here Is Why - Yahoo Finance
Little Excitement Around Bausch + Lomb Corporation's (NYSE:BLCO) Revenues - 富途牛牛
Bausch + Lomb Corporation - Baystreet.ca
Complete Custom Contact Lens Portfolio: Bausch + Lomb Launches ASANA for Complex Vision Conditions - Stock Titan
Is Bausch + Lomb Corporation being accumulated by smart money2025 Big Picture & Fast Momentum Entry Tips - خودرو بانک
Can trapped investors hope for a rebound in Bausch + Lomb CorporationTrade Entry Summary & Low Volatility Stock Suggestions - Newser
Is Bausch + Lomb Corporation exposed to currency risksJuly 2025 Movers & Low Risk High Win Rate Stock Picks - خودرو بانک
Nicox Expects to Fully Repay Financial Debts with NCX 470 De-Risked and Globally Licensed - GlobeNewswire Inc.
Is Bausch + Lomb Corporation stock reversal real or fakeWeekly Stock Report & Low Risk High Win Rate Stock Picks - Newser
Is Bausch + Lomb Corporation backed by strong institutional buyingBond Market & Daily Entry Point Alerts - خودرو بانک
Will Bausch + Lomb Corporation continue its uptrend2025 Technical Patterns & Free Community Consensus Stock Picks - Newser
Tools to assess Bausch + Lomb Corporation’s risk profileJuly 2025 Volume & Fast Exit and Entry Strategy Plans - Newser
Is Bausch + Lomb Corporation stock a falling knife or bargain buyEarnings Recap Report & Safe Entry Point Alerts - khodrobank.com
Sector ETF performance correlation with Bausch + Lomb CorporationWeekly Investment Report & Community Verified Swing Trade Signals - Newser
Is Bausch + Lomb Corporation stock bottoming outJuly 2025 Technicals & Fast Moving Stock Watchlists - Newser
Visualizing Bausch + Lomb Corporation stock with heatmapsTrade Performance Summary & AI Optimized Trade Strategies - Newser
Can volume confirm reversal in Bausch + Lomb CorporationEarnings Risk Report & High Return Stock Watch Alerts - Newser
What to expect from Bausch + Lomb Corporation in the next 30 daysWeekly Stock Analysis & AI Enhanced Market Trend Forecasts - Newser
Analyzing Bausch + Lomb Corporation with multi timeframe chartsTake Profit & Risk Controlled Stock Pick Alerts - Newser
Technical signs of recovery in Bausch + Lomb CorporationForecast Cut & Weekly Consistent Profit Watchlists - Newser
Tools to monitor Bausch + Lomb Corporation recovery probabilityVolume Spike & AI Driven Price Forecasts - Newser
Using Bollinger Bands to evaluate Bausch + Lomb CorporationEarnings Recap Summary & AI Enhanced Trading Alerts - Newser
What’s next for Bausch + Lomb Corporation stock priceQuarterly Portfolio Summary & Community Verified Watchlist Alerts - Newser
Can swing trading help recover from Bausch + Lomb Corporation lossesTrade Analysis Summary & Target Return Focused Picks - Newser
Bausch Lomb Corp Stock (BLCO) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.58%
0.49%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):